PEREGRINE PHARMACEUTICALS IN's ticker is PPHMXXXX and the CUSIP is 713661304. A total of 63 filers reported holding PEREGRINE PHARMACEUTICALS IN in Q1 2017. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $232,000 | +45.0% | 380,048 | +54.8% | 0.00% | – |
| Q1 2017 | $160,000 | +1233.3% | 245,551 | +534.5% | 0.00% | – |
| Q4 2016 | $12,000 | +100.0% | 38,700 | +178.4% | 0.00% | – |
| Q3 2016 | $6,000 | -45.5% | 13,900 | -53.0% | 0.00% | – |
| Q2 2016 | $11,000 | +83.3% | 29,586 | +124.2% | 0.00% | – |
| Q1 2016 | $6,000 | -90.0% | 13,198 | -74.4% | 0.00% | – |
| Q4 2015 | $60,000 | +328.6% | 51,649 | +283.0% | 0.00% | – |
| Q3 2015 | $14,000 | +180.0% | 13,486 | +291.2% | 0.00% | – |
| Q4 2014 | $5,000 | -75.0% | 3,447 | -76.4% | 0.00% | – |
| Q3 2014 | $20,000 | -69.2% | 14,586 | -57.7% | 0.00% | – |
| Q2 2014 | $65,000 | -33.7% | 34,509 | -33.1% | 0.00% | – |
| Q1 2014 | $98,000 | +96.0% | 51,604 | +42.2% | 0.00% | – |
| Q4 2013 | $50,000 | -67.3% | 36,302 | -69.4% | 0.00% | – |
| Q2 2013 | $153,000 | – | 118,703 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BAXTER BROS INC | 170,506 | $232,000 | 0.09% |
| First Heartland Consultants, Inc. | 86,204 | $117,000 | 0.05% |
| Rotella Capital Management, Inc. | 20,769 | $28,000 | 0.03% |
| FIDGEON TIMOTHY F | 33,000 | $45,000 | 0.02% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 547,800 | $746,000 | 0.02% |
| Freedom Investment Management, Inc. | 74,127 | $101,000 | 0.02% |
| Investors Capital Advisory Services | 63,288 | $86,000 | 0.02% |
| REYNOLDS CAPITAL MANAGEMENT LLC | 10,000 | $14,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 76,914 | $104,000 | 0.01% |
| PINNACLE FINANCIAL PARTNERS INC | 20,000 | $27,000 | 0.01% |